Resources

Supervised consumption sites (SCS) have been implemented across Canada to mitigate harms associated with illegal substance use.

Indigenous Canadians experience a disproportionate burden of substance-related harms compared to their non-Indigenous counterparts.

This intrinsic case study offers a unique perspective on the operation of Drug User Liberation Frontʼs Compassion Club and Fulfillment Centre, delving into its inception, development, implementatio

The COVID-19 pandemic was associated with increases in the prevalence of depression and anxiety among children and young adults.

This commentary discusses the report commissioned by the Alberta government in 2019 to review the socioeconomic impacts of seven supervised consumption services in the province.

This study examined drug policy stakeholders’ perspectives on the structure, function, and fit of a four pillar drug strategy framework in Vancouver, Canada.

This scoping review aimed to 1) examine the extent, type, and characteristics of evidence regarding women's OUD treatment experiences, and 2) describe the extent to which patient-reported experienc

There remains limited qualitative community-based evidence on the role of cannabis co-use among opioid using and injecting populations.

Much existing research is characterized by a primary focus on the “online” aspects of drug sales facilitated by social media, resulting in a divide between “on”- and “offline” drug dealing.

This is a report from the Office of the Provincial Health Officer in British Columbia highlighting the urgent need to expand access to alternatives to unregulated drugs during the toxic drug crisis

Prior research has demonstrated the importance of involving people who use drugs in harm reduction intervention design and implementation.

In many jurisdictions, policies restrict access to Opioid Agonist Treatment (OAT) in correctional facilities.

Within the context of a public health programme called ‘safer injection education', this article explores how the materialises of drug use (such as paraphernalia and space) intersect with habitual

Gendered differences were explored in how people relate to stimulant use, their motivations for using, and how that manifests in the ways that they engage with and use methamphetamine. 

We assessed the relationship between distribution of safer smoking supplies by syringe services programs (SSPs) and levels of participant engagement and naloxone distribution.

To develop a clinical guideline for opioid withdrawal management in acute National Health Service (NHS) hospital trusts to be tested and evaluated as part of the iHOST (Improving Hospital Opioid Su

Police seizures of illegal opioids remain a dominant strategy for addressing substance use and overdose in the United States and throughout the world, yet qualitative accounts and quantitative anal

Illegal drug toxicity (i.e., overdose) is the leading cause of death in British Columbia (BC) for people aged 10–59. Stimulants are increasingly detected among drug toxicity deaths.

Support for a human rights framework for drug policy has been growing for some years.

It has been suggested that opioid agonist therapy (OAT) may have a secondary benefit of reducing methamphetamine/amphetamine use.